Would you like to assess the productivity of a cell line and the quality of the antibodies before negotiating a license contract or developing a test?
Would you like to anticipate the regulations on animal experimentation?
Would you like to meet your growing needs for antibodies?
Vos lignées cellulaires représentent une part importante de votre propriété industrielle, souvent le résultat de mois ou d'années de développement.
Leur perte peut avoir des conséquences dramatiques pour votre activité.
Pour vous, nous avons développé une solution de sécurisation de vos hybridomes.
Read more: Cell banking : Gestion sécurisée des lignées cellulaires
TCR studies at P.A.R.I.S: Step by step: a timely and cost effective approach
Are you working on an antibody drug candidate? Do you need to characterized it?
Tissue Cross-Reactivity studies give key data for the development of monoclonal antibodies. They assure that the experimental antibody binds to the target site and does not bind to epitopes other than the target what could lead to treatment-related toxicity in humans.
P.A.R.I.S offers Tissue Cross-Reactivity studies, both GLP and non-GLP in support of your research or your preclinical therapeutic antibody development.
Enhance similarity to human at reasonable costs.
P.A.R.I.S proposes a service of antibody chimerization. Our technology preserves the specificity and affinity of the antibody toward the antigen whereas significantly reduces the immunogenicity of the antibody in humans.
P.A.R.I.S works from any isotype and you choose the final isotype: IgA or IgG.
Chaque anticorps réagit différemment aux techniques de purification auxquelles il est soumis. Une purification adaptée est le meilleur compromis entre le degré de pureté et le rendement.
Page 1 of 3